Tyra Biosciences, Inc.TYRANASDAQ
LOADING
|||
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-6.30%
↑ 60% above average
Average (22q)
-15.93%
Historical baseline
Range
High:20.32%
Low:-59.37%
Volatility
-500.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -6.30% |
| Q2 2025 | 0.17% |
| Q1 2025 | -10.07% |
| Q4 2024 | -6.47% |
| Q3 2024 | -28.41% |
| Q2 2024 | -2.80% |
| Q1 2024 | 20.32% |
| Q4 2023 | -7.93% |
| Q3 2023 | -59.37% |
| Q2 2023 | -11.72% |
| Q1 2023 | 7.87% |
| Q4 2022 | -3.09% |
| Q3 2022 | 17.13% |
| Q2 2022 | -1.81% |
| Q1 2022 | -49.31% |
| Q4 2021 | -49.48% |
| Q3 2021 | -20.52% |
| Q2 2021 | -30.96% |
| Q1 2021 | -14.22% |
| Q4 2020 | -57.55% |
| Q3 2020 | -27.26% |
| Q2 2020 | -24.69% |
| Q1 2020 | 0.00% |